DIN 02479214 — ALUNBRIG 90 MG
ALUNBRIG is a tablet of Brigatinib marketed by TAKEDA CANADA INC. The full Brigatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02479214
- Brand name
- ALUNBRIG
- Active ingredient
- Brigatinib
- Strength
- 90 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TAKEDA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Brigatinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02479222 | ALUNBRIG | 180 MG | TABLET | TAKEDA CANADA INC | MARKETED |
| 02479230 | ALUNBRIG | 180 MG; 90 MG | KIT; TABLET | TAKEDA CANADA INC | MARKETED |
| 02479206 | ALUNBRIG | 30 MG | TABLET | TAKEDA CANADA INC | MARKETED |